Article content
OAKVILLE, Ontario — GL CHEMTEC, a leading North American-based CDMO providing advanced chemistry services to the pharmaceutical and biotech sectors, is pleased to announce the completion of our state-of-the-art Good Manufacturing Practice (GMP) Kilo lab facility. This strategic expansion strengthens our commitment to delivering high-quality materials to our valued customers across the pharmaceutical and life science sectors.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
The new, fully operational Kilo scale GMP facility will serve increased customer demand for advanced materials suitable for use in human clinical trials. This investment enables GL CHEMTEC to bridge the gap between pre-clinical offerings and first-in-human, offering our clients a seamless pathway from concept to clinic and commercialization.
Article content
Article content
Article content
“Our new Kilo lab GMP facility represents a significant milestone in GL CHEMTEC’s growth strategy,” said Dr. Gamil Alhakimi, CEO. “By enhancing our capabilities in material science and drug delivery, we can better serve our customers with faster development cycles, superior quality control, and more efficient scaling processes.”
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Key features of the new GMP facility:
Article content
- Two state-of-the-art specialized rooms designed to meet ISO 8 particulate and microbiological specifications
- Enhanced quality control systems
- Significantly increased production capacity at the multi-Kilogram scale
- A dedicated team of world-class Biomedical Polymer Science and Drug Delivery experts
Article content
The facility is now fully operational and accepting new projects. Current customers can contact their GL CHEMTEC representative for more information on how this new capability can benefit their existing and future projects. Prospective clients are invited to visit the GL CHEMTEC website to learn more.
Article content
“This investment is a further testament to GL CHEMTEC’s unwavering commitment to advancing drug development and delivery solutions,” Dr. Alhakimi stated. “We are now better positioned to support our partners in navigating the complexities of scale-up and clinical trials, ultimately contributing to a healthier future.”
Article content
About GL CHEMTEC
Article content
Over the last two decades, GL CHEMTEC has established itself as a leader in the life sciences sector, delivering sustainable, innovative solutions with unparalleled speed and passion. The company’s track record of success is rooted in an unwavering commitment to their customers and their unique ability to adapt to diverse needs through a flexible, collaborative approach. Located in North America, GL CHEMTEC provides a secure supply chain, enabling accelerated early-stage API development and the seamless transition of innovative drug delivery solutions from research and development to manufacturing.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
Media Contact – Katy Bartow, Senior Director, [email protected], Mezzanine Growth
Article content
Article content